| Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis M Prinz, F Garbe, H Schmidt, A Mildner, I Gutcher, K Wolter, M Piesche, ... The Journal of clinical investigation 116 (2), 456-464, 2006 | 484 | 2006 |
| Soluble PD-L1 as a biomarker in malignant melanoma and checkpoint blockade HFS Zhou J, Mahoney KM, Giobbie-Hurder A, Zhao F, Lee S, Liao X, Rodig S, Li ... cancer immunology research, 2017 | 360* | 2017 |
| Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors R Schroers, Y Hildebrandt, J Hasenkamp, B Glass, A Lieber, G Wulf, ... Experimental hematology 32 (6), 536-546, 2004 | 78 | 2004 |
| Identification of a promiscuous HLA DR–restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin M Piesche, Y Hildebrandt, F Zettl, B Chapuy, M Schmitz, G Wulf, ... Human immunology 68 (7), 572-576, 2007 | 69 | 2007 |
| Combined anti-VEGF and anti-CTLA-4 therapy elicits humoral immunity to galectin-1 which is associated with favorable clinical outcomes X Wu, J Li, EM Connolly, X Liao, J Ouyang, A Giobbie-Hurder, ... Cancer Immunology Research, canimm. 0385.2016, 2017 | 61 | 2017 |
| Vaccination with irradiated autologous tumor cells mixed with irradiated GM-K562 cells stimulates antitumor immunity and T lymphocyte activation in patients with recurrent … WT Curry Jr, R Gorrepati, M Piesche, T Sasada, P Agarwalla, PS Jones, ... Clinical Cancer Research 22 (12), 2885-2896, 2016 | 55 | 2016 |
| Ion Channel Function During Oocyte Maturation and Fertilization KM I Carvacho , M Piesche, TJ Maier Frontiers in cell and developmental biology 6, 63, 2018 | 48 | 2018 |
| Regulation of tumorigenic Wnt signaling by cyclooxygenase-2,5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells? MTJ Roos J, Grösch S, Werz O, Schröder P, Ziegler S, Fulda S, Paulus P ... Pharmacol Ther., 2016 | 48 | 2016 |
| Casein kinase 1 delta (CK1δ) interacts with the SNARE associated protein snapin S Wolff, M Stöter, G Giamas, M Piesche, D Henne-Bruns, G Banting, ... FEBS letters 580 (27), 6477-6484, 2006 | 48 | 2006 |
| Adipose tissue macrophages as a therapeutic target in obesity‐associated diseases AA Herrada, A Olate‐Briones, A Rojas, C Liu, N Escobedo, M Piesche Obesity Reviews 22 (6), e13200, 2021 | 43 | 2021 |
| The emerging therapeutic potential of nitro fatty acids and other Michael acceptor-containing drugs for the treatment of inflammation and cancer M Piesche, J Roos, B Kühn, J Fettel, N Hellmuth, C Brat, IV Maucher, ... Frontiers in pharmacology 11, 1297, 2020 | 42 | 2020 |
| RGD‐binding integrins and TGF‐β in SARS‐CoV‐2 infections–novel targets to treat COVID‐19 patients? I Carvacho, M Piesche Clinical & Translational Immunology 10 (3), e1240, 2021 | 40 | 2021 |
| Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418 IV Maucher, M Ruehl, SBM Kretschmer, B Hofmann, B Kuehn, J Fettel, ... Biochemical Pharmacology 125, 55-74, 2017 | 30 | 2017 |
| Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT GDRJS Vincent T. Ho, Haesook T. Kim, Natalie Bavli, Martin Mihm, Olga ... Blood advances 1 (24), 2115-2301, 2017 | 21* | 2017 |
| Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity EDWS Huntington KE, Carlsen L, So EY, Piesche M, Liang O Pharmaceuticals 17 (15(5)), 618, 2022 | 20* | 2022 |
| Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions Clinical Cancer Research 21 (5), 1010-8, 2015 | 12 | 2015 |
| Effects of interleukin-1β in glycinergic transmission at the central amygdala J Solorza, CA Oliva, K Castillo, G Amestica, MC Maldifassi, ... Frontiers in Pharmacology 12, 613105, 2021 | 7 | 2021 |
| Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3 M Piesche, Y Hildebrandt, B Chapuy, GG Wulf, L Trümper, R Schroers Vaccine 27 (34), 4718-4723, 2009 | 6 | 2009 |
| Drug-mediated intracellular donation of nitric oxide potently inhibits 5-lipoxygenase: a possible key to future antileukotriene therapy J Roos, M Peters, IV Maucher, B Kühn, J Fettel, N Hellmuth, C Brat, ... Antioxidants & Redox Signaling 28 (14), 1265-1285, 2018 | 4 | 2018 |
| Identifikation und immunologische Charakterisierung von MHC-Klasse-II-Peptidepitopen in humanen Leukämie-und Lymphom-assoziierten Antigenen M Piesche | 1 | 2006 |
Marco PrinzProfessor of Neuropathology, University Hospital Freiburg在 uniklinik-freiburg.de 的电子邮件经过验证
